BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 27599722)

  • 1. Reactivation of mutant p53 by capsaicin, the major constituent of peppers.
    Garufi A; Pistritto G; Cirone M; D'Orazi G
    J Exp Clin Cancer Res; 2016 Sep; 35(1):136. PubMed ID: 27599722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 mutant-type in human prostate cancer cells determines the sensitivity to phenethyl isothiocyanate induced growth inhibition.
    Aggarwal M; Saxena R; Asif N; Sinclair E; Tan J; Cruz I; Berry D; Kallakury B; Pham Q; Wang TTY; Chung FL
    J Exp Clin Cancer Res; 2019 Jul; 38(1):307. PubMed ID: 31307507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivation of mutant p53 by a dietary-related compound phenethyl isothiocyanate inhibits tumor growth.
    Aggarwal M; Saxena R; Sinclair E; Fu Y; Jacobs A; Dyba M; Wang X; Cruz I; Berry D; Kallakury B; Mueller SC; Agostino SD; Blandino G; Avantaggiati ML; Chung FL
    Cell Death Differ; 2016 Oct; 23(10):1615-27. PubMed ID: 27258787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TAR1, a human anti-p53 single-chain antibody, restores tumor suppressor function to mutant p53 variants.
    Orgad S; Dimant H; Dor-On E; Azriel-Rosenfeld R; Benhar I; Solomon B
    J Immunother; 2010; 33(2):146-54. PubMed ID: 20139776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer Properties of Capsaicin Against Human Cancer.
    Clark R; Lee SH
    Anticancer Res; 2016 Mar; 36(3):837-43. PubMed ID: 26976969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fluorescent curcumin-based Zn(II)-complex reactivates mutant (R175H and R273H) p53 in cancer cells.
    Garufi A; Trisciuoglio D; Porru M; Leonetti C; Stoppacciaro A; D'Orazi V; Avantaggiati M; Crispini A; Pucci D; D'Orazi G
    J Exp Clin Cancer Res; 2013 Oct; 32(1):72. PubMed ID: 24220325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Andrographolide induces degradation of mutant p53 via activation of Hsp70.
    Sato H; Hiraki M; Namba T; Egawa N; Baba K; Tanaka T; Noshiro H
    Int J Oncol; 2018 Aug; 53(2):761-770. PubMed ID: 29845212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-molecule modulators of p53 family signaling and antitumor effects in p53-deficient human colon tumor xenografts.
    Wang W; Kim SH; El-Deiry WS
    Proc Natl Acad Sci U S A; 2006 Jul; 103(29):11003-8. PubMed ID: 16835297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations.
    Li X; Wu JB; Chung LW; Huang WC
    Oncotarget; 2015 Dec; 6(38):41018-32. PubMed ID: 26512780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLMP53-1 interacts with wild-type and mutant p53 DNA-binding domain and reactivates multiple hotspot mutations.
    Gomes AS; Ramos H; Gomes S; Loureiro JB; Soares J; Barcherini V; Monti P; Fronza G; Oliveira C; Domingues L; Bastos M; Dourado DFAR; Carvalho AL; Romão MJ; Pinheiro B; Marcelo F; Carvalho A; Santos MMM; Saraiva L
    Biochim Biophys Acta Gen Subj; 2020 Jan; 1864(1):129440. PubMed ID: 31536751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zn(II)-curc targets p53 in thyroid cancer cells.
    Garufi A; D'Orazi V; Crispini A; D'Orazi G
    Int J Oncol; 2015 Oct; 47(4):1241-8. PubMed ID: 26314369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterisation of p53 mutants identified in breast cancers with suboptimal responses to anthracyclines or mitomycin.
    Berge EO; Huun J; Lillehaug JR; Lønning PE; Knappskog S
    Biochim Biophys Acta; 2013 Mar; 1830(3):2790-7. PubMed ID: 23246812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Elemene against human lung cancer via up-regulation of P53 protein expression to promote the release of exosome.
    Li J; JunYu ; Liu A; Wang Y
    Lung Cancer; 2014 Nov; 86(2):144-50. PubMed ID: 25204604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ghost pepper on cell proliferation, apoptosis, senescence and global proteomic profile in human renal adenocarcinoma cells.
    Perla V; Nadimi M; Reddy R; Hankins GR; Nimmakayala P; Harris RT; Valluri J; Sirbu C; Reddy UK
    PLoS One; 2018; 13(10):e0206183. PubMed ID: 30379886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New therapeutic strategies to treat human cancers expressing mutant p53 proteins.
    Blandino G; Di Agostino S
    J Exp Clin Cancer Res; 2018 Feb; 37(1):30. PubMed ID: 29448954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pepper's natural ingredient capsaicin induces autophagy blockage in prostate cancer cells.
    Ramos-Torres Á; Bort A; Morell C; Rodríguez-Henche N; Díaz-Laviada I
    Oncotarget; 2016 Jan; 7(2):1569-83. PubMed ID: 26625315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression.
    Bossi G; Lapi E; Strano S; Rinaldo C; Blandino G; Sacchi A
    Oncogene; 2006 Jan; 25(2):304-9. PubMed ID: 16170357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status.
    Garufi A; Baldari S; Pettinari R; Gilardini Montani MS; D'Orazi V; Pistritto G; Crispini A; Giorno E; Toietta G; Marchetti F; Cirone M; D'Orazi G
    J Exp Clin Cancer Res; 2020 Jun; 39(1):122. PubMed ID: 32605658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoring p53 active conformation by zinc increases the response of mutant p53 tumor cells to anticancer drugs.
    Puca R; Nardinocchi L; Porru M; Simon AJ; Rechavi G; Leonetti C; Givol D; D'Orazi G
    Cell Cycle; 2011 May; 10(10):1679-89. PubMed ID: 21508668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivation of mutant p53: molecular mechanisms and therapeutic potential.
    Selivanova G; Wiman KG
    Oncogene; 2007 Apr; 26(15):2243-54. PubMed ID: 17401433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.